Anabolic deficiencies in men with systolic heart failure: Do co-morbidities and therapies really contribute significantly?

Elzbieta Kalicińska; Katarzyna Wojtas; Jacek Majda; Wolfram Doehner; Stephan Von Haehling; Waldemar Banasiak; Beata Ponikowska; Ludmila Borodulin-Nadzieja; Stefan D. Anker; Piotr Ponikowski; Ewa A. Jankowska

doi:10.3109/13685538.2013.807427

Anabolic deficiencies in men with systolic heart failure: Do co-morbidities and therapies really contribute significantly?

Elzbieta Kalicińska, Katarzyna Wojtas, Jacek Majda, Wolfram Doehner, Stephan Von Haehling, Waldemar Banasiak, Beata Ponikowska, Ludmila Borodulin-Nadzieja, Stefan D. Anker, Piotr Ponikowski, Ewa A. Jankowska

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Deficiencies of anabolic hormones are common in men with heart failure (HF). It remains unclear whether the deranged metabolism of these hormones is the pathophysiological element of HF itself or is the consequence of co-morbidities or/and treatment in HF. Methods: We examined 382 men with systolic HF. Serum hormones (i.e. total testosterone [TT], DHEAS, IGF-1) were assessed using immunoassays, serum free testosterone (eFT)-using the Vermeulen equation. Results: Prevalence of TT and eFT deficiencies was similar in men with HF aged

Original language	English
Pages (from-to)	123-131
Number of pages	9
Journal	Aging Male
Volume	16
Issue number	3
DOIs	https://doi.org/10.3109/13685538.2013.807427
Publication status	Published - Sep 2013

Keywords

Anabolic deficiency
Dehydroepiandrosterone sulphate
Heart failure
Insulin-like growth factor 1
Male ageing
Testosterone

ASJC Scopus subject areas

Geriatrics and Gerontology

Access to Document

10.3109/13685538.2013.807427

Fingerprint Dive into the research topics of 'Anabolic deficiencies in men with systolic heart failure: Do co-morbidities and therapies really contribute significantly?'. Together they form a unique fingerprint.

Cite this

Kalicińska, E., Wojtas, K., Majda, J., Doehner, W., Haehling, S. V., Banasiak, W., Ponikowska, B., Borodulin-Nadzieja, L., Anker, S. D., Ponikowski, P., & Jankowska, E. A. (2013). Anabolic deficiencies in men with systolic heart failure: Do co-morbidities and therapies really contribute significantly? Aging Male, 16(3), 123-131. https://doi.org/10.3109/13685538.2013.807427

Anabolic deficiencies in men with systolic heart failure : Do co-morbidities and therapies really contribute significantly? / Kalicińska, Elzbieta; Wojtas, Katarzyna; Majda, Jacek; Doehner, Wolfram; Haehling, Stephan Von; Banasiak, Waldemar; Ponikowska, Beata; Borodulin-Nadzieja, Ludmila; Anker, Stefan D.; Ponikowski, Piotr; Jankowska, Ewa A.

In: Aging Male, Vol. 16, No. 3, 09.2013, p. 123-131.

Research output: Contribution to journal › Article › peer-review

Kalicińska, E, Wojtas, K, Majda, J, Doehner, W, Haehling, SV, Banasiak, W, Ponikowska, B, Borodulin-Nadzieja, L, Anker, SD, Ponikowski, P & Jankowska, EA 2013, 'Anabolic deficiencies in men with systolic heart failure: Do co-morbidities and therapies really contribute significantly?', Aging Male, vol. 16, no. 3, pp. 123-131. https://doi.org/10.3109/13685538.2013.807427

Kalicińska, Elzbieta ; Wojtas, Katarzyna ; Majda, Jacek ; Doehner, Wolfram ; Haehling, Stephan Von ; Banasiak, Waldemar ; Ponikowska, Beata ; Borodulin-Nadzieja, Ludmila ; Anker, Stefan D. ; Ponikowski, Piotr ; Jankowska, Ewa A. / Anabolic deficiencies in men with systolic heart failure : Do co-morbidities and therapies really contribute significantly?. In: Aging Male. 2013 ; Vol. 16, No. 3. pp. 123-131.

@article{2d2b751a43424024a480b6ea8276fe8a,

title = "Anabolic deficiencies in men with systolic heart failure: Do co-morbidities and therapies really contribute significantly?",

abstract = "Background: Deficiencies of anabolic hormones are common in men with heart failure (HF). It remains unclear whether the deranged metabolism of these hormones is the pathophysiological element of HF itself or is the consequence of co-morbidities or/and treatment in HF. Methods: We examined 382 men with systolic HF. Serum hormones (i.e. total testosterone [TT], DHEAS, IGF-1) were assessed using immunoassays, serum free testosterone (eFT)-using the Vermeulen equation. Results: Prevalence of TT and eFT deficiencies was similar in men with HF aged",

keywords = "Anabolic deficiency, Dehydroepiandrosterone sulphate, Heart failure, Insulin-like growth factor 1, Male ageing, Testosterone",

author = "Elzbieta Kalici{\'n}ska and Katarzyna Wojtas and Jacek Majda and Wolfram Doehner and Haehling, {Stephan Von} and Waldemar Banasiak and Beata Ponikowska and Ludmila Borodulin-Nadzieja and Anker, {Stefan D.} and Piotr Ponikowski and Jankowska, {Ewa A.}",

year = "2013",

month = sep,

doi = "10.3109/13685538.2013.807427",

language = "English",

volume = "16",

pages = "123--131",

journal = "Aging Male",

issn = "1368-5538",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Anabolic deficiencies in men with systolic heart failure

T2 - Do co-morbidities and therapies really contribute significantly?

AU - Kalicińska, Elzbieta

AU - Wojtas, Katarzyna

AU - Majda, Jacek

AU - Doehner, Wolfram

AU - Haehling, Stephan Von

AU - Banasiak, Waldemar

AU - Ponikowska, Beata

AU - Borodulin-Nadzieja, Ludmila

AU - Anker, Stefan D.

AU - Ponikowski, Piotr

AU - Jankowska, Ewa A.

PY - 2013/9

Y1 - 2013/9

N2 - Background: Deficiencies of anabolic hormones are common in men with heart failure (HF). It remains unclear whether the deranged metabolism of these hormones is the pathophysiological element of HF itself or is the consequence of co-morbidities or/and treatment in HF. Methods: We examined 382 men with systolic HF. Serum hormones (i.e. total testosterone [TT], DHEAS, IGF-1) were assessed using immunoassays, serum free testosterone (eFT)-using the Vermeulen equation. Results: Prevalence of TT and eFT deficiencies was similar in men with HF aged

AB - Background: Deficiencies of anabolic hormones are common in men with heart failure (HF). It remains unclear whether the deranged metabolism of these hormones is the pathophysiological element of HF itself or is the consequence of co-morbidities or/and treatment in HF. Methods: We examined 382 men with systolic HF. Serum hormones (i.e. total testosterone [TT], DHEAS, IGF-1) were assessed using immunoassays, serum free testosterone (eFT)-using the Vermeulen equation. Results: Prevalence of TT and eFT deficiencies was similar in men with HF aged

KW - Anabolic deficiency

KW - Dehydroepiandrosterone sulphate

KW - Heart failure

KW - Insulin-like growth factor 1

KW - Male ageing

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=84883563275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883563275&partnerID=8YFLogxK

U2 - 10.3109/13685538.2013.807427

DO - 10.3109/13685538.2013.807427

M3 - Article

C2 - 23803163

AN - SCOPUS:84883563275

VL - 16

SP - 123

EP - 131

JO - Aging Male

JF - Aging Male

SN - 1368-5538

IS - 3

ER -